[Neurotransmitter-receptor-imaging]
- PMID: 7904078
[Neurotransmitter-receptor-imaging]
Abstract
The importance of neuroreceptor imaging in vivo using single photon emission tomography (SPECT) and positron emission tomography (PET) has increased enormously. The principal neurotransmitters, such as dopamine, GABA/benzodiazepine, acetylcholine, and serotonin, are presented with reference to anatomical, biochemical, and physiological features. The main radioligands for SPECT and PET are introduced, and methodological characteristics of both PET and SPECT are summarized. Finally, the results of neurotransmitter receptor imaging obtained so far will be discussed.
Similar articles
-
Applications of neuroreceptor imaging to psychiatry research.Psychopharmacol Bull. 2003;37(4):26-65. Psychopharmacol Bull. 2003. PMID: 15131516 Review.
-
Brain radioligands--state of the art and new trends.Q J Nucl Med. 2001 Jun;45(2):139-52. Q J Nucl Med. 2001. PMID: 11476163 Review.
-
Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights.Q J Nucl Med. 2001 Jun;45(2):124-38. Q J Nucl Med. 2001. PMID: 11476162 Review.
-
An introduction to PET and SPECT neuroreceptor quantification models.J Nucl Med. 2001 May;42(5):755-63. J Nucl Med. 2001. PMID: 11337572 Review.
-
[Receptor occupancy and antipsychotic drug action measured by PET and SPECT].Seishin Shinkeigaku Zasshi. 2001;103(4):329-40. Seishin Shinkeigaku Zasshi. 2001. PMID: 11392846 Review. Japanese.